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CHAPTER I 
INTRODUCTION 
In the United States, venomous snakes are responsible for 6,000-
8,000 human bites each year (Russell, 1969). Because of the availability 
of medical treatment and the use of antivenom, the mortality from 
snakebite in the U.S. is low with fewer than twelve deaths per year 
(Minton, 1971). However, the local damage caused by the venoms, 
including hemorrhage, edema, and myonecrosis continues to be an important 
clinical concern and can result in the loss of function of the 
envenomated region. 
The treatment for snakebite is varied, but depends on factors such 
as the diagnosis of the bite due to a venomous snake, the amount of 
venom injected, and the length of time elapsed before reaching medical 
assistance (Klauber, 1956). The diagnosis of venomous snakebite is often 
difficult and depends on both the presence of clinical signs of 
envenomation and the positive identification of the snake. However, in 
many cases the snake responsible for the bite is not seen or is mis-
identified by the patient. In these cases the accurate identification of 
the snake responsible can be extremely difficult especially in areas 
where multiple species of venomous snakes inhabit the same region. 
In the state of Oklahoma, U.S.A., there are seven species of 
venomous snakes, all of which belong to the family Viperidae, subfamily 
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Crotalinae. Copperheads (Agkistrodon contortrix) are common throughout 
the eastern two thirds of Oklahoma and bites by these snakes represent a 
high percentage of the total number of snakebites in the state (Parrish, 
1980). Although rarely fatal, copperhead bites can produce significant 
local damage which includes primarily edema, erythema, and subcutaneous 
hemorrhage. The treatment for these cases usually consists of fluid 
therapy and corticosteroids; the use of antivenom is generally not 
required. On the other hand, bites by other crotaline snakes found in 
Oklahoma, such as rattlesnakes, can produce both local and systemic 
effects resulting in death, and the use of a polyvalent antivenom is 
often recommended for serious cases. The administration of the 
antivenom, however, increases the risk of hypersensitivity to the horse 
serum which is especially important if the victim should receive a future 
bite and require serotherapy. Therefore, although the treatment for 
snakebite is based on clinical signs, a more conservative treatment may 
be employed, especially with regard to the administration of antivenom, 
if the snake responsible is identified and known to produce less serious 
bites in humans. Since copperhead bites are usually not life-threatening 
and do not require the use of antivenom, it would be beneficial in 
treating snakebite in the U.S. to identify the snake responsible as 
either a copperhead or other crotaline snake. This is especially 
important in areas of the country with large populations of copperheads 
and the snakes represent a high percentage of snakebite cases. 
Clinical assays have been developed which can detect and identify 
specific venoms in snakebite victims where the identity of the snake was 
not known. The most commom method is to use an immunoassay to identify 
the venom in body fluids such as serum, urine, and bite site washings. 
Immunodiffusion, radioimmunoassays, and enyme-linked immunoassays have 
all been used with varied success in detecting the presence of venoms 
(Muelling et al., 1957; Coulter et al., 1978; Theakston et al., 1977). 
However, each of these assays has limitations that must be considered in 
a clinical application. Immunodiffusion is relatively easy and does not 
require sophisticated laboratory equipment but is less sensitive than 
other immunoassays and can only detect immune complexes in microgram 
concentrations. Radioimmunoassays have a high sensitivity, detecting 
venom in nanogram concentrations, but require the use of reagents that 
are labile and cannot be stored for long periods of time. Enzyme-linked 
immunoassays also have high a sensitivity, however, non-specific binding 
and cross-reactions can be a problem (Ho et al., 1986a). 
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The detection of specific venoms in serum and urine from snakebite 
victims using an enzyme-linked immunosorbent assay (ELISA) has been 
reported (Coulter et al., 1980; Ho et al., 1986b). The limitations of 
the assay based on possible interactions between snake venoms and human 
serum components and variations in serum and urine from individuals, 
however, have not been thoroughly investigated. The purpose of the 
following investigation, therefore, was to develop an ELISA to detect the 
presence of copperhead venom in serum and urine from snakebite victims 
and investigate possible limitations of the assay in clinical 
applications. Cross-reactions between antisera to copperhead venoms and 
venoms from taxonomically related snakes was also investigated to 
determine how this may influence the identification of snakes involved in 
snakebite in the United States. 
CHAPTER II 
LITERATURE REVIEW 
Venomous snakes in the United States belong to either the subfamily 
Crotalinae or the family Elapidae. The Crotalinae or pit vipers are 
represented by the true rattlesnakes, genus Crotalus, the ground 
rattlesnakes, genus Sistrurus, and the copperheads and water moccasins, 
genus Agkistrodon. The Elapidae are represented by two genera of coral 
snake, Micruoides and Micrurus. In the U.S., the majority of serious 
human bites are caused by crotaline snakes; the coral snakes, although 
possessing a potent neurotoxic venom, are responsible for only about 1% 
of the total number of snakebites (Parrish, 1980). 
Snake venoms are complex mixtures composed primarily of proteins that 
possess a wide range of biological activities (Tu, 1977). Snake venoms 
have historically been classified as either hemotoxic or neurotoxic to 
describe their primary mode of action on the cardiovascular system or 
nervous system, respectively (Minton, 1974). Because of their 
complexity, however, specific venoms have been found that produce 
deleterious effects on numerous organ systems of the body. For example, 
the venom of the African spitting cobra (Naja nigricollis), a 
predominantly neurotoxic venom, has been shown to also produce local 
damage such as myonecrosis and hemorrhage in humans (Reid, 1964). 
Conversely, the venoms from rattlesnakes are considered to be primarily 
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hemotoxic although the Mojave rattlesnake (Crotalus scutulatus 
scutulatus) produces a venom that causes little hemorrhage and contains 
high concentrations of a presynaptic neurotoxin (Castilonia et al., 
1980). 
Copperheads and Their Venoms 
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Copperheads (Agkistrodon contortrix) are small, crotaline snakes 
that inhabit the central and southeastern regions of the United States. 
In the springtime, copperheads can be found basking during the daytime on 
rocky outcroppings in grassy fields and along small streams. As the 
summer progresses, however, they become more active in the evening hours 
and eventually will become nocturnal. At this time they can be found 
crossing roads and in open meadows in search of food which includes 
primarily rodents, birds, lizards, and amphibians. It is also at this 
time that many people are bitten by copperheads. However, since other 
snakes, including both venomous and non-venomous species, are also active 
at night during summer, it is often difficult to identify the snake as a 
copperhead if a bite should occur. 
The biological activities of copperhead venoms have not been as 
thoroughly investigated as those of veno~s from other snakes. Copperhead 
venoms have been shown to produce considerable local tissue damage such 
as myonecrosis, edema, and hemorrhage (Mebs et al., 1983) although they 
are generally not as toxic as other crotaline venoms. Minton (1974) 
reported an intravenous LD/50 of 10.0 mg/ml for southern copperhead (~ 
~ contortrix) venom which is approximately 10 times less toxic than the 
venom of the cottonmouth (~ piscivorus), a closely related snake. Moran 
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~ al. (1979) fractionated northern copperhead(~~ mokeson) venom into 
9 components using carboxymethyl cellulose chromatography. One of the 
fractions was responsible for 65-70% of the lethality of the whole venom 
and had a subcutaneous LD/50 of 1-2 mg/kg. 
The enzymatic activities of copperhead venoms have been reported by 
many researchers. Tu et al. (1965) showed that the venoms from 
copperheads possess considerable proteolytic activity on synthetic 
substrates such as TAME and BAEE. They also found that proteolytic 
activity was widely distributed in many venoms from snakes in the 
subfamilies Crotalinae and Viperinae but not in the family Elapidae. 
Kocholaty et al. (1971) in a comprehensive study of some of the enzymatic 
properties of venoms from crotaline, viperine, and elapid snakes also 
showed considerable proteolytic activity in copperhead venoms. In 
addition they found that copperhead venoms had the highest 1-amino acid 
oxidase activity of venoms from 29 snake species tested with the 
exception of~~ viridis venom. They also showed that copperhead 
venoms did not possess any phosphodiesterase activity but did have 
moderate phospholipase A2 activity. In isolating the phospholipase A2 
component from~~ contortrix venom, Welches et al. (1985) demonstrated 
that most activity was found in a monomeric protein with a molecular 
weight of 8,000-10,000. The monomeric phospholipase Az from members of 
the genus Agkistrodon was different from those found in species of the 
genus Crotalus which are usually dimeric molecules. 
The venoms from copperheads have also been shown to have pronounced 
effects on the vascular system. Bajwa et al. (1982) showed that crude A. 
-- -
c. contortrix venom exhibited fibrinolytic activity using the fibrin 
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plate assay but did not show any thrombin-like activity. However, after 
fractionation on Sephadex G-100 both fibrinolytic and thrombin-like 
activities were found in fractions with molecular weights of 73,500 and 
25,000, respectively, Herzig et al. (1970) using column chromatography 
also separated the venom of~~ contortrix into fibrinolytic and 
procoagulant fractions. The procoagulant fraction clotted fibrinogen 
directly and had proteolytic, esterolytic, and amidase activities. The 
fraction released fibrinopeptide B at a much faster rate than 
fibrinopeptide A, however, a visible clot did not form until considerable 
amounts of fibrinopeptide A were released. Markland et al. (1985) 
isolated a fibrinolytic enzyme from~~ contortrix venom using eM-
cellulose, Sephadex G-100, benzamidine-Sepharose, and isoelectric 
focusing that was a single chain glycoprotein that had a molecular weight 
of 25,000 using SDS-PAGE. The fraction was free of thrombin-like 
activity and acted both directly on fibrin formed by thrombin clotting of 
human fibrinogen and on a fibrin clot using the fibrin plate assay. 
Distribution of Venoms in Envenomated Animals 
The distribution of radiolabelled snake venoms in experimental 
animals has been well documented. Lee and Tseng (1966) showed that in 
rabbits injected intravenously with iodinated venom from the banded krait 
(Bungarus multicinctus), the highest concentration of venom was 
distributed in the kidney followed in decreasing order by the lungs, 
spleen, heart, stomach, intestine, diaphram and skeletal muscle. The 
distribution of the venom in the kidney was also considerably higher than 
in blood samples taken from the carotid artery. Lebez et al. (1973) in a 
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study using Vipera ammodytes venom also showed a high concentration of 
Se-75-labeled fractions in the kidney of artificially injected mice. 
High concentrations of venom have also been reported in the urine of 
animals injected with snake venoms. In a study using rabbits, Shu et al. 
(1968) showed that 70% of cobrotoxin labeled with I-131 is excreted in 
the urine within 5 hours of a single intravenous injection. 
Detection of Venom Using Immunoassays 
Clinical immunoassays that have detected a specific venom in 
snakebite victims where the snake was not identified at the time of the 
bite have been described. Sutherland and Coulter (1977) using a 
radioimmunoassay with I-125-labeled rabbit IgG against several Australian 
elapid venoms were able to detect the presence of tiger snake (Notechis 
scutatus) venom in urine and extracts from clothing in two of three 
unusual snakebite cases in which the patients were found unconscious. 
Post-mortem examination of one of the patients where death occured before 
antivenom could be administered revealed traces of N. scutatus venom in 
skin from the possible bite site as well as in blood, liver, and urine 
samples. 
The use of an enzyme linked immunosorbent assay (ELISA) for the 
identification of snake venoms has also been described. Theakston et al. 
(1977) used an ELISA for the detection of snake venoms in a test system 
as well as in experimental animals. Using 14 venoms from different 
species diluted in normal human serum and normal rat serum they were able 
to detect the venoms in concentrations of 1-5 ng/ml. Antisera against 
venoms from Naja haje, ~ nigricollis, Bitis arietans, Causus maculatus, 
and Echis carinatus did not cross react with any of the 14 venoms with 
the exception of the venom from~ naja reacting against the ~ haje 
antiserum. Blood samples taken from mice injected i.v. (0.4 mg/kg) with 
E. carinatus venom showed high venom concentrations up to 2 hr, however, 
levels were just detectable after 24 hr. After subcutaneous injection 
(6.0 mg/kg), venom levels in the blood were low after 24 hr, reached a 
maximum after 48 hr, and then remained relatively constant. for 3 weeks. 
The authors also showed similar results using rats. 
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Coulter et al. (1980) developed a clinical ELISA for the rapid 
identification of the snake species involved in snakebite in Australia. 
By using horseradish peroxidase-labeled rabbit IgG against several 
crotaline, viperine, and elapid snake venoms, they were able to identify 
the snake responsible for the bite by detecting the presence of specific 
venoms in swab eluates of the bite site. Later, Chandler and Hurrell 
(1982) described a modification of an ELISA which allowed for the 
identification of snake venom in blood, urine, and bite site washings 
that does not require the use of sophisticated laboratory equipment and 
is suitable for field use. The assay utilizes capillary tubes coated 
with monospecific antisera against a variety of different snake venoms. 
The test sample is drawn into each capillary tube and after washing, a 
secondary antibody conjugated to urease is added to the tubes. Urea is 
used as substrate and the amount of ammonia released is determined by a 
decrease in pH and is measured by a visible color change of Bromocresol 
purple. In a review of the assay after two years of clinical use in 
Australia, Hurrell and Chandler (1982) showed that in 38 patients showing 
definite signs of venom poisoning, the identity of the snake was 
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determined in 31 of the cases. However, 6 patients showed definite signs 
of envenomation but were negative when tested using five monospecific 
antisera against venoms from the snakes responsible for the majority of 
snakebite in Australia. 
Interaction of Serum Components and Snake Venom 
The interaction of snake venoms and serum components from a variety 
of animals has been reported. Venomous snakes are one group of animals 
that have been shown to possess serum components that interact with both 
their own venom and the venoms from other snake species. Omori-Satoh et 
al. (1972) isolated an antihemorrhagic factor from the serum of the habu 
snake (Trimeresurus flavoviridis) that effectively neutralized the 
hemorrhagic activity of its venom. The purified component had a 
molecular weight of 70,000, an isoelectric point of about 4.0, and 
migrated similarly to albumin and alpha-1 globulin using 
immunoelectrophoresis. They also showed that the crude serum from T. 
flavoviridis inhibited hemorrhagic activity of a variety of crotaline, 
viperine, and elapid snake venoms. Ovadia (1978) isolated a factor from 
the serum of the snake Vipera palaestinae that neutralized all the 
hemorrhagic activity of its venom. It had a molecular weight of about 
80,000, an isoelectric point of 4.7, and did not form precipitin bands 
against the venom using immunodiffusion. These results suggested that it 
was not an immunoglobulin but was probably an albumin or alpha-globulin. 
Sera from non-venomous snakes have also been shown to contain 
factors that interact with venom components. The serum of the florida 
kingsnake (Lampropeltis getulus floridana) was fractionated into 3 
components that effectively inhibited the proteolytic activity of water 
moccasin (~ piscivorus) venom (Bonnett and Guttman, 1971). All three 
fractions migrated similarly to the gamma-globulins using 
electrophoresis, and the inhibition was thought to result from the 
combination of gamma-globulin antibodies with antigenic venom proteases. 
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The inhibition of snake venom components by the sera from mammals has 
also been reported. Pichyangkul and Perez (1981) isolated a component 
from the serum of the hispid cotton rat (Sigmodon hispidus) that 
neutralized the hemorrhagic activity of Crotalus atrox venom. The 
molecular weight of the factor was about 90,000 and it had an isoelectric 
point of 5.4. Neither the crude serum or purified component formed a 
precipitin line against ~ atrox venom using immunodiffusion. These 
results suggested that the factor was probably an alpha-globulin which 
had characteristics similar to the antihemorrhagic factors isolated from 
some snake sera. An antihemorrhagic factor isolated from the serum of 
the opossum (Didelphis virginiana) was shown to have a molecular weight 
of 68,000 and an isoelectric point of 4.1 (Menchaca and Perez, 1981). 
They suggested that the antihemorrhagic factor from opossum serum is 
probably an albumin or closely associated with albumin. 
Human alpha-2 macroglobulin or its equivalent in animals is another 
serum component that has been shown to interact with certain snake venom 
proteases. Kress and Catanese (1981) demonstrated that the addition of 
0.1 mg human alpha-2 macroglobulin to 14 snake venoms resulted in 40-80% 
inhibition of the proteolytic activity of the venom. However, Crotalus 
adamanteus venom retained approximately SO% of its proteolytic activity 
even after addition of 1.5 mg alpha-2 macroglobulin. C. adamanteus peak 
12 
I proteinase, which is responsible for most of the proteolytic activity 
of C. adamanteus venom, also retained 75-80% of its original activity in 
the presence of human alpha-2 macroglobulin. Since alpha-2 macroglobulin 
was in excess, the residual proteolytic activity of peak I proteinase 
suggests that some venom proteinases are only slightly inactivated by 
complex formation with alpha-2 macroglobulin. Pitney and Regoeczi (1970) 
also showed a short-lived complex of human alpha-2 macroglobulin with-the 
thrombin-like esterase from A. rhodostoma venom. 
In a study using non-human macroglobulins, DeWit and Westrom (1987) 
isolated 3 fractions from serum of the European hedgehog that were able 
to neutralize all hemorrhagic activity of European viper (Vipera berus) 
venom. The proteins migrated in the alpha-2, alpha-2-beta, and beta 
region on agarose electrophoresis and showed inhibiting activity against 
trypsin, chymotrpsin, elastase, collagenase, papain, and plasmin. 
Polyacrylamide gel electrophoresis showed one band corresponding to a 
molecular weight of 780,000 and three weak bands with molecular weights 
of 670,000, 550,000, and 539,000. Using immunoelectrophoresis, the 
alpha-2 protein cross-reacted with antisera against human alpha-2 
macroglobulin, swine alpha-2 macroglobulin, and rat alpha-2 acute phase 
globulin while the alpha-2-beta and beta proteins cross-reacted with 
swine alpha-2 macroglobulin. 
Cross-reaction between Snake Venoms 
Chemical differences in the venoms of taxonomically distinct snake 
species have been shown by many researchers. However, since the turn of 
the century, many common components in snake venoms have been reported. 
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In an early study on the antigenic composition of snake venoms, Lamb 
(1902) showed precipitin reactions between venoms of Russell's viper (~ 
russelli), saw-scaled viper(~ carinatus), banded krait(~ fasciatus), 
and tiger snake (~ scutatus) and antiserum prepared in rabbits against 
venom of the Indian cobra (~ naja naja). Minton (1968) using 
immunodiffusion showed that the venom from Wagler's pit viper 
(Trimeresurus wagleri) has at least six venom components common with 
other members of the genus. Also, the venoms from~ okinavenis, T. 
albolabris, and~ wagleri all cross-reacted with antiserum to T. 
flavoviridis. Venoms of three American and two Asian species of 
Agkistrodon were studied by Tu and Adams (1968) who found that 
immunologic differences were roughly proportional to geographic distance 
between species. However, the venom of~ halys blomhoffii of Japan was 
antigenically as close to ~ contortrix and ~ piscivorus of North 
America as to A. rhodostoma of Southeast Asia. Among Asian Agkistrodon, 
venoms from~~ blomhoffii, ~~ brevicaudus, ~ caliginosus, and~ 
~ caucasius gave similar immunodiffusion patterns while those of A. 
acutus and A. rhodostoma differed markedly from this group. 
Purified components isolated from specific snake venoms have also 
been shown to be distributed among both taxonomically related and 
distinct snakes. Weinstein et al. (1985) isolated Mojave toxin from the 
venom of~~ scutulatus and produced an antiserum against it in 
rabbits. Using an ELISA, they found high amounts present in 4 of 6 ~~ 
scutulatus venoms, 2 of 3 ~ durissus venoms, and in venom samples from 
C. viridis concolor and~ tigris. Low amounts were present in one~~ 
scutulatus venom sample, 2 of 12 C. atrox venoms, and one T. flavoviridis 
venom sample. The toxin was absent in the venoms tested from species of 
Agkistrodon, Sistrurus, and Vipera. 
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CHAPTER III 
CASE HISTORIES 
In this investigation serum and urine from three snakebite victims 
from Oklahoma were screened for the presence of copperhead venom using an 
enzyme-linked immunosorbent assay. All three patients developed clinical 
signs consistent with bites by copperheads, however, in all cases the 
identity of the snake was not accurately determined, Case histories for 
these patients are presented below. 
Patient #1 
Locale- Pottawatomie County, Oklahoma; Subject- Caucasian female; 
Age- 26. Circumstance and etiology. On the night of 3 June, 1986 the 
subject was walking through a pasture near her home when she was bitten 
on the left foot by an un-identified snake. Within a few minutes a 
burning sensation developed in the foot which soon spread up to the calf 
and thigh. The following morning the pain was still present and the 
patient was transported to the Springdale Medical Clinic in Oklahoma 
City. Oklahoma. Upon arrival at the clinic, vital signs were normal and 
the foot was swollen but not vesiculated. The toes were strutted and 
tender to palpation. Areas of discoloration were present around the bite 
site and on the dorsum of the foot proximal to the toes. On 5 June, 1986 
the foot was still swollen and the edema had spread to the calf. Areas 
15 
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of ecchymosis were present over much of the foot, calf, and thigh and 
left inguinal adenopathy was present. The patient was treated 
conservatively with corticosteroids and allowed to go home. On 18 June, 
1986 the swelling and ecchymosis were decreased and the foot was normal 
size. No eschar or tissue loss resulted and the patient recovered 
without complication. 
Patient #2 
Locale- Logan County, Oklahoma; Subject- Caucasian female; Age- 20. 
Circumstance and etiology. On the night of 14 July, 1984 the subject was 
walking near a pond when she was bitten on top of the right foot by an 
un-identified snake. Considerable pain and edema developed in the foot 
and the patient was admitted to the Mercy Hospital in Oklahoma City, 
Oklahoma at 3:45 a.m. At this time swelling extended to the knee and 
right inguinal adenopathy was present. The foot and calf were tender to 
palpation but were not vesiculated. Ecchymosis extended from the bite 
site to the ankle and the calf. Antivenom was withheld because of 
clinical findings and the risk of sensitization. ~ 
On 16 July, 1984 the discoloration of the foot was slightly 
increased, however, there was good movement of all digits and sensory 
functions were intact. Excellent micro-circulation in the toes was 
demonstrated using a doppler recording. The swelling, adenopathy, and 
ecchymosis gradually decreased and the patient was dicharged on 18 July, 
1984. The patient recovered without complication and retained complete 
movement of all digits. 
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Patient #3 
Locale- Caddo County, Oklahoma; Subject- American Indian male; Age-
13. Circumstance and etiology. On the night of 16 June, 1985 the 
patient was home working in his garage when he reached back for a tool 
and was bitten on the second digit of the first finger of the left hand 
by a snake believed to be a copperhead. He was admitted to Deaconess 
Hospital in Oklahoma City, Oklahoma early 17 June, 1985. He appeared to 
be in some distress, principally by anxiety over his condition. 
Examination of the left extremity revealed a slight draining of 
serosanguous material from two puncture wounds of the volar aspect of the 
second digit of the first finger. Considerable discoloration extended 
from the digit into the hand and the entire area was markedly tender to 
palpation. Edema continued to develop in the hand, and the patient was 
skin tested for antivenin. This was negative and the patient was given 
two vials (20 cc) of Wyeth's Polyvalent (Crotalidae) antivenin. He 
responded well to treatment and demonstrated no allergic reaction to the 
antivenin. The patient was discharged from the hospital on 20 June, 1985 
at which time the swelling had decreased and he had good joint movement 
in the digit, wrist, and elbow. An eschar developed at the bite site 
which was later replaced by scar tissue. 
CHAPTER IV 
MATERIALS AND METHODS 
Venoms 
Lyophilized southern copperhead(~~ contortrix) venom was 
purchased from Biotoxins Inc., St. Cloud, Fl, U.S.A (Lot# AC/85A). Venom 
from the northern copperhead(~~ mokeson) was purchased in lyophilized 
form from Miami Serpentarium Laboratories, Salt Lake City, Utah, U.S.A 
(Lot# AM7SZ). For cross-reaction studies, venoms from twenty four 
species of Crotalus inhabiting the U.S., Mexico, and Central and South 
America were kindly donated by James Glenn, Venomous Animals Research 
Laboratory, Veterans Administration Hospital, Salt Lake City, Utah, 
U.S.A. 
Production of Antisera 
Antisera against both~~ contortrix and~~ mokeson venoms were 
prepared in New Zealand white rabbits using the technique of Ownby et al. 
(1979). Venoms were first diluted in 0.85% saline to a concentration of 
1.0 mg/ml. One milliliter of the venom solution was mixed with an equal 
volume of Freund's complete adjuvant (DIFCO Laboratories, Detroit, MI) 
and injected intramuscularly between the shoulder blades. A booster 
injection containing 1.0 ml of the venom solution mixed with an equal 
volume of Freund's incomplete adjuvant was given one week after the 
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initial injection and then again approximately every two months. The 
rabbits were bled from the marginal ear vein two weeks after the first 
booster injection and again approximately every month. Sera were 
collected and centrifuged for 10 minutes at a setting of 7 on a IEC 
clinical centrifuge to remove cellular debris. Aliquots of the sera were 
stored at -20°C until needed. 
Detection of Antibodies 
Sera from the bleedings were tested for the presence of antibodies 
to either~~ contortrix or~~ mokeson venoms using Ouchterlony 
double immunodiffusion in 1% agarose gels (Ownby~ al., 1979). 
Diffusion plates were prepared by adding 5.0 rnl of agarose to small Petri 
dishes. Six wells were then cut into the gel; the diameter of the wells 
was 0.5 em and the distance from center to center of wells was 1.0 ern. 
The wells were filled twice with ca. 20 microliters of either homologous 
venom or antivenorn and the plates allowed to develop at room temperature 
for 48 hours. 
Enzyme-Linked Irnrnunosorbent Assay 
The indirect and double-antibody methods of an enzyme-linked 
irnmunosorbent assay (ELISA) were both used to test serum and urine 
samples from three snakebite patients seen at the Springdale Medical 
Clinic, Oklahoma City, Oklahoma, for the presence of copperhead venom 
using rnonospecific antisera against venoms from either~~ contortrix 
or~~ rnokeson. In addition, both assays were used to test for 
possible interference of the ELISA by human serum components while the 
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indirect ELISA was used to test the degree of cross-reaction between 
copperhead antiserum and other crotaline snake venoms. 
Indirect ELISA. Two hundred microliters of test sample or controls 
were added to wells of polystyrene microtiter plates (Flow Laboratories, 
el McLean, VA.) and coated overnight at 4 C. The plates were washed 3 times 
in washing buffer containing NaCl and Tween 20 allowing a 5 minute 
soaking between each wash step. Two hundred microliters of a 1.0% bovine 
serum albumin (aqueous) were then added to each well and incubated for 1 
0 hour at 37 C as a blocking step. The plates were again washed three 
times and dilutions (1:500, 1:750, 1:1000,) of crude antisera against 
either venoms from A. c. contortrix or A. c. mokeson in incubation buffer 
-- --
containing PBS, Tween 20, and NaN3 were added to the wells and the plates 
0 incubated at 37 C for 2 hours. After washing, 0.2 ml of a 1:1000 
dilution of a goat anti-rabbit IgG-alkaline phosphatase conjugate (Sigma 
Chemical Co., Inc.) in incubation buffer was added and the plates 
0 incubated for 2 hours at 37 C. The plates were washed a final time and 
0.2 ml of a 1.0 mg/ml solution of p-nitrophenyl phosphate (Sigma, Inc.) 
in diethanolamine buffer added to each well as substrate. The substrate 
was incubated for either 20, 30 or 60 minutes and the reaction stopped by 
the addition of 0.05 ml of 3 M NaOH to the wells. The absorbance of each 
well was determined at 405 nm using a Bio-Tek EL 307 ELISA plate reader. 
Incubation buffer and serum and urine purchased from Ciba Corning 
Diagnostic Corporation (Irvine, CA.) were used as negative controls. A 
standard curve of known amounts of venom ranging from 1000 to 1.97 ng/ml 
were made in incubation buffer, control serum, and control urine and run 
on each plate. 
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Double-Antibody ELISA. The double-antibody ELISA method was the 
same as described for the indirect method with the exception that 0.2 ml 
of a 1:1000 dilution of the crude antiserum in coating buffer (pH 9.6) 
were added to each well of polystyrene microtiter plates and coated 
0 
overnight at 4 C. The plates were washed and 0.2 ml of test samples or 
0 
controls added to the wells and incubated for 2 hours at 37 C. The 
remainder of the assay including the addition of antibody, conjugate, and 
substrate was run as described for the indirect ELISA. 
Determination of Interference of ELISA ~ 
Serum Components 
Possible interference of the ELISA by certain human serum components 
was investigated using both the indirect and double-antibody ELISA 
methods. Human alpha-2 macroglobulin and human IgG purchased from Sigma 
Chemical, Inc. were diluted in incubation buffer (pH 7.4) to 
concentrations of 5.0 mg/ml and 10.0 mg/ml, respectively and added to 
separate standards of~~ contortrix venom. The standards ranged from 
250 to 15.8 ng/ml and were prepared by making serial dilutions of the 
venom in incubation buffer and adding the appropriate amount of the 
alpha-2 macroglobulin or IgG stock so that each dilution contained either 
0.5 mg/ml alpha-2 macroglobulin or 5.0 mg/ml human IgG. A third standard 
was prepared by making serial dilutions of~~ contortrix venom in 
incubation buffer containing 20.0 mg/ml human serum albumin (Sigma, 
Inc.). A fourth standard consisted of only~~ contortrix venom in 
incubation buffer. 
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Determination of Cross-Reaction 
Cross-reactions between antisera against venoms from~~ 
contortrix or A. c. mokeson and venoms from 24 crotaline snakes were 
--
investigated using the indirect ELISA method. Lyophilized venoms were 
reconstituted in incubation buffer to a concentration of 1.0 mg/ml. 
Wells on polystyrene microtiter plates were loaded with 0.2 ml of the 
venom solutions and coated overnight at 4 C. The assay was then 
performed as described for the indirect ELISA method. Venoms that gave 
an absorbance greater than 2.0 at 405 nm were diluted 1:1000 in 
incubation buffer and the assay repeated. Venoms that cross-reacted with 
either antisera were scored semi-quantitatively based on their 
absorbances at 405 nm compared to the homologous venoms. 
Statistical Analysis 
The Student's t-test (p less than or equal to 0.05) was used to 
determine the statistical significance between test samples and negative 
controls. 
CHAPTE~ V 
RESULTS 
Detection of Antibodies 
Ouchterlony immunodiffusion showed the presence of antibodies in 
both antisera to A. c. contortrix and A. c. mokeson venoms. Four 
-- --
precipitin bands formed between homologous venom and antiserum to~~ 
contortrix venom whereas 3 precipitin bands formed between antiserum to 
~~ mokeson venom and homologous venom. 
Double Antibody ELISA. 
Determination of Parameters. Preliminary studies were done to 
determine both the substrate incubation time and concentration of 
conjugate that would provide maximum sensitivity and minimum non-specific 
binding of conjugate in each well. Table I shows the results of a 1:500, 
1:1000, and 1:2000 dilution of conjugate and a 30 minute substrate 
incubation using a 1:1000 dilution of antiserum to~~ contortrix venom 
as primary antibody. The highest sensitivity and lowest non-specific 
binding was obtained with a 1:1000 dilution of conjuate. At this 
concentration, the assay detected venom at approximately 30 ng/ml. 
Although a slightly higher sensitivity was obtained using a 1:500 
dilution, high absorbance values were present in the negative controls 
and suggested increased non-specific binding of the conjugate. 
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TABLE I 
STANDARD CURVES OF A. C. CONTORTRIX VENOM USING THE DOUBLE-ANTIBODY 
ELIS~AND THREE DILUTIONS OF CONJUGATE 
Venom (ng/ml) 
1000 
500 
250 
125 
62.5 
31.3 
15.6 
7.8 
3.9 
1.9 
IB 
1/500 
1.72 
0. 72 
0.48 
0.27 
0.22 
0.18 
0.16 
0.19 
r=.99 
1/1000 1/2000 
1.81 
1.99 1.15 
1.04 0.73 
0.46 0.35 
0.29 0.19 
0.21 0.14 
0.18 0.12 
0.15 0.12 
0.13 0.13 
0.16 0.13 
r=.99 r=.99 
Absorbance values are expressed as the mean of duplicate wells; - off 
scale, absorbance greater than 2.0 
Substrate incubation = 30 minutes, IB = Incubation buffer, 
r = correlation coefficient 
All standard errors were less than 0.17 
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At 60 minutes substrate incubation, the highest sensitivity and 
lowest background were again obtained with a 1:1000 dilution of 
conjugate. At 60 minutes, a 1:1000 dilution had a slightly higher 
sensitivity compared to 30 minutes, detecting venom at about 15 ng/ml, 
however, the absorbance of control blanks was about 50% higher. Because 
of the lower non-specific binding with a 1:1000 dilution at 30 minute 
substrate incubation, these parameters were chosen for the remainder of 
the assays. 
Human Serum and Urine Samples. The results from screening serum and 
urine samples from possible snakebite patients for the presence of 
copperhead venom using the double-antibody ELISA are shown in Table II. 
Because of high absorbance values in negative serum and urine controls, 
the only samples giving significant positive results using the antiserum 
to~~ contortrix venom were urine samples from patient #2 on both the 
day of the bite and on the day following the bite. Using the antiserum 
against~~ mokeson venom, a positive reaction occured only in the 
urine from patient #2 on the second day following the bite (results not 
shown). 
Interference EY Human Serum Components 
Figures 1-3 show the results of the addition of human alpha-2 
macroglobulin, human IgG, and human serum albumin to standards of~~ 
contortrix venom. Absorbance values of the standards made with alpha-2 
macroglobulin were approximately 30-35% lower compared to the standards 
made in incubation buffer or containing human serum albumin. However, 
standards made with human IgG gave approximately 40% higher absorbance 
TABLE II 
SCREENING SERUM AND URINE FROM POSSIBLE SNAKEBITE PATIENTS FOR THE 
PRESENCE OF COPPERHEAD VENOM USING THE DOUBLE-ANTIBODY ELISA AND 
ANTISERUM TO A. C. CONTORTRIX VENOM 
Date of Absorbance Significant 
Sample at 405 nm 
Patient #1 
Serum 6/04/86 0.14 
6/05/86 0.17 
6/09/86 0.16 
6/11/86 0.15 
Urine 6/05/86 0.34 
6/09/86 0.30 
6/11/86 0.31 
Patient #2 
Serum 7/15/85 0.23 
7/16/85 0.20 
7/18/85 0.18 
Urine 7/15/85 0.38 + 
7/16/85 0.47 + 
7/17/85 0.27 
7/18/85 0.29 
Absorbance values are expressed as the mean of duplicate well 
All standard errors were less than 0.09 
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Figure 1. Inhibition of A. c. contortrix venom standards by human 
alpha-2 macroglobulin using the double-antibody ELISA. IB= 
standards made in incubation buffer only, a2-M = standards 
made in incubation buffer containing 0.5 mg/ml human alpha-2 
macroglobulin. Absorbance values are expressed as the mean 
of duplicate wells, standard errors ranged from 0.02-0.007. 
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Figure 2. Effect of human IgG on the reactivity of standards of~~ 
contortrix venom using the double-antibody ELISA. IB = 
standards made in incubation buffer only, IgG = standards 
made in incubation buffer containing 5,0 mg/ml human IgG. 
Absorbance values are expressed as the mean of duplicate 
wells, standard errors ranged from 0.01-0.009. 
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Figure 3. Effect of human serum albumin on the reactivity of standards 
of~~ contortrix venom using the double-antibody ELISA. 
IB = standards made in incubation buffer only, HSA = 
standards made in incubation buffer containing 20 mg/ml 
human serum albumin. Absorbance values are expressed as 
means of duplicate wells, standard errors ranged from 0.01-
0.007. 
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values at venom concentrations of 15.8 and 31.7 ng/ml compared to 
standards made with human albumin or in incubation buffer. 
Indirect ELISA 
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Determination of Parameters. Parameters such as primary antibody 
concentration, conjugate concentration, and substrate incubation times 
giving the highest sensitivity and lowest non-specific binding were 
determined in a manner similar to that described for the double antibody 
ELISA. The results of standards (1000 to 15.8 ng/ml) using a 1:1000 
dilution of conjugate, 60 minutes substrate incubation, and two different 
dilutions of antiserum to .!.:__ .£:_ contortrix venom ( 1:500 and 1: 1000) are 
shown in Table III. The sensitivity of the assay using the indirect 
method was slightly higher than with the double antibody method, and it 
was able to detect venom at a concentration of approximately 15 ng/ml. A 
1:750 dilution of primary antibody gave lower blank values yet had the 
same sensitivity as a 1:500 dilution. Also, reducing the substrate 
incubation time from 60 minutes to as low as 20 minutes did not affect 
the sensitivity of the assay yet reduced the absorbance values of control 
blanks. Therefore, a 1:750 dilution of primary antibody, a 1:1000 
dilution of conjugate, and a 20 minute substrate incubation gave the 
highest sensitivity and lowest non-specific binding and were thus used 
for the remainder of the indirect ELISA assays. 
Human Serum and Urine Samples. Table IV shows the results of 
screening serum and urine samples from snakebite patients using the 
indirect ELISA method and antiserum against.!.:__.£:_ contortrix venom. The 
indirect ELISA resulted in lower absorbance values in control blanks and 
TABLE III 
STANDARD CURVES OF A. C. CONTORTRIX VENOM USING THE INDIRECT ELISA 
AND TWO DILUTIONS OF PRIMARY ANTIBODY 
Venom (ng/ml) 
1000 
500 
250 
125 
62.5 
37.5 
15.8 
7.8 
3.9 
1.9 
IB 
1/500 
1.97 
0.81 
0.73 
0.43 
0.29 
0.20 
0.23 
0.21 
0.20 
r=.99 
1/1000 
1.89 
0.64 
0.56 
0.36 
0.27 
0.16 
0.17 
0.17 
0.17 
r=.98 
Absorbance values are expressed as the mean of duplicate wells; - off 
scale, absorbance greater than 2.0 
Substrate incubation= 60 minutes, conjugate = 1:1000 
r = correlation coefficient 
All standard errors were less than 0.07 
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TABLE IV 
SCREENING SERUM AND URINE FROM POSSIBLE SNAKEBITE PATIENTS FOR THE 
PRESENCE OF COPPERHEAD VENOM USING THE INDIRECT ELISA AND 
ANTISERUM TO A. C. CONTORTRIX VENOM 
Date of Absorbance Significant 
Sample at 405 nm 
Patient #1 
Serum 6/04/86 0.21 
6/05/86 0.26 
6/09/86 0.26 
6/11/86 0.23 
Urine 6/05/86 0.26 
6/09/86 0.29 
6/11/86 0.41 + 
Patient #2 
Serum 7/15/85 0.28 
7/16/85 0.29 
7/18/85 0.35 + 
Urine 7/15/85 0.34 + 
7/16/85 0.41 + 
7/17/85 0.49 + 
7/18/85 0.27 
Patient #3 
Serum 6/17/86 0.48 + 
6/19/86 0.19 
6/24/86 0.21 
Urine 6/17/86 0.38 + 
6/19/86 0.35 + 
6/24/86 0.28 
Absorbance values are expressed as the mean of duplicate wells 
. 
All standard errors were less than 0.05 
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an increase in the number of samples with significant positive reactions 
compared to the double-antibody method. In general, urine samples from 
all three patients were more likely to give positive results than were 
serum samples. The only sample from patient #1 that gave a positive 
reaction was urine from the second day after the bite. Serum from 
patient #2 gave a positive reaction on the third day following the bite 
while urine samples from patient #2 were positive the same day of the 
bite and on the second and third day following the bite. The serum from 
patient #3 tested positive on same day as the bite but not on subsequent 
days. The urine from patient #3 gave positive results on both the same 
day of the bite and the second day following the bite. 
As a control, normal serum and urine from several different 
individuals and human serum and urine purchased from a commercial source 
were assayed using the indirect ELISA and antiserum to~~ contortrix 
venom. The results showed a considerable individual variation in the 
absorbance of serum and urine samples. The absorbance of these serum 
samples ranged from 0.24 to 0.49 whereas urine samples varied from 0.22 
to 0.45. The serum and urine taken from one of the control individuals 
over a seven day period, however, showed very little day to day variation 
in absorbance. The absorbance of serum samples varied by only 0.01 
absorbance units between the first and seventh day while the urine varied 
by 0.04 units. 
Interference ~ Human Serum Components 
Figures 4 and 5 show the result of an indirect ELISA using~~ 
contortrix venom standards made in either normal human serum or urine. 
Figure 4. Results of an indirect ELISA using standards of A. c. 
contortrix venom diluted in either incubation buffer or 
control human serum. 
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Figure 5. Results of an indirect ELISA using standards of~~ 
contortrix venom diluted in either incubation buffer or 
control human urine. 
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The standards made in human serum resulted in absorbance values 
approximately 60% less than standards made in incubation buffer at venom 
concentrations ranging from 250 to 62.5 ng/ml. Human urine, however, did 
not inhibit the ELISA and standards made in urine had absorbance values 
slightly higher than standards made in incubation buffer. 
The standards of~~ contortrix venom containing 0.5 mg/ml human 
alpha-2 macroglobulin showed a 25% reduction in absorbance at a venom 
concentration of 250.0 ng/ml compared to standards made in incubation 
buffer or with human serum albumin. However, venom concentrations from 
125 to 15.8 ng/ml were not significantly different. Similar to the 
double-antibody ELISA, standards made with human IgG gave approximately 
60% higher absorbance values at 62.5 ng/ml, 31.7 ng.ml, and 15.8 ng/ml 
compared to the standards in incubation buffer or containing human serum 
albumin. 
Determination of Cross-reaction 
All twenty-four crotaline venoms tested cross-reacted with both 
antisera against~~ contortrix venom and~~ mokeson venom (Table 
V). Venoms from the canebrake rattlesnake (~ horridis atricaudatus), 
Central American rattlesnake (~ durissus durissus), banded-rock 
rattlesnake(~ lepidus klauberi), midget-faded rattlesnake(~~ 
concolor), and prairie rattlesnake(~~ viridis) showed the least 
amount of cross-reaction with the antiserum to A. c. contortrix venom 
whereas Cedros Island rattlesnake (~ exsul) venom had the highest cross-
reaction. Using the antiserum against~~ mokeson venom,~~ 
atricaudatus and C. exsul venoms had the least and greatest cross-
reaction, respectively. 
TABLE V 
CROSS-REACTIONS BETWEEN CROTALINE SNAKE VENOMS AND ANTISERUM 
TO A. C. CONTORTRIX VENOM 
Venom Sample 
A. c. contortrix 
(Southern copperhead) 
A. c. mokeson 
(Northern copperhead) 
C. basilicus basilicus 
(Mexican West-Coast rattlesnake) 
C. catalensis 
(Santa Catalina Island rattlesnake) 
C. cerastes cerastes 
(Mojave Desert sidewinder) 
C. durissus culminatus 
(Northwestern Neotropical rattlesnake) 
C. durissus durissus 
(Central American rattlesnake) 
C. durissus totanacus 
(Totonacan rattlesnake) 
.f:_ enyo enyo 
(Lower Californian rattlesnake) 
C. exsul 
(Cedros Island rattlesnake) 
C. horridus atricaudatus 
(Canebrake rattlesnake) 
C. horridus horridus 
CTimber rattlesnake) 
.f:.. lepidus ldauberi 
(Banded-Rock rattlesnake) 
Degree of Cross-Reactivity 
+++++ 
+++++ 
+++ 
++ 
++ 
+++ 
+ 
++ 
+++ 
++++ 
+ 
++ 
+ 
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TABLE V (Continued) 
Venom Sample Degree of Cross-Reactivity 
C. mitchellii pyrhuss 
(Southwestern speckled rattlesnake) 
~ mitchellii stephensi 
(Panamint rattlesnake) 
~ molossus nigrescens 
(Mexican black-tailed rattlesnake) 
C. ruber ruber 
(Red diamond rattlesnake) 
~ vergrandis 
(Urocoan rattlesnake) 
C. viridis cerberus 
CArizon black rattlesnake) 
C. viridis concolor 
(Midget-faded rattlesnake) 
C. viridis helleri 
(Southern Pacific rattlesnake) 
~ viridis oreganus 
(Northern Pacific rattlesnake) 
C. viridis viridis 
(Prairie rattlesnake) 
C. = Crotalus, A. = Agkistrodon 
Concentration of venom samples was 0.001 mg/ml 
+++ 
++ 
++ 
++ 
++ 
++ 
+ 
+++ 
++ 
+ 
Cross-reactivity is expressed as the absorbance at 405 nm as follows: 
+: 0.0-0.50 absorbance units 
++: 0.51-1.0 absorbance units 
+++: 1.01-1.5 absorbance units 
++++: 1. 51-2.0 absorbance units 
+++++: > 2.0 absorbance units 
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CHAPTER VI 
DISCUSSION 
The use of an enzyme-linked immunosorbent assay (ELISA) for the 
detection of copperhead (Agkistrodon contortrix) venom in serum and urine 
from snakebite victims and its possible role as a clinical tool for the 
diagnosis of venomous snakebite in the United States was investigated. 
In this study, two different ELISA methods were used; the indirect ELISA 
in which the antigen was adsorbed directly to wells of polystyrene 
microtiter plates, and the double-antibody ELISA in which antigen was 
bound to immunoglobulins that were adsorbed to wells of the microtiter 
plates. Using standards of~~ contortrix venom made in incubation 
buffer, the double-antibody ELISA was able to detect venom at a 
concentration of about 30 ng/ml. However, high absorbance values in 
negative controls using serum and urine made evaluation of the human 
samples difficult. The indirect ELISA resulted in lower absorbance 
values in negative controls when using human serum and urine and had a 
slightly higher sensitivity compared to the double-antibody method. For 
this reason, the indirect ELISA method appears superior in screening 
possible snakebite patients for the presence of venom in their serum and 
urine. 
Using the indirect ELISA with~~ contortrix antiserum, the assay 
gave positive results in at least some of the serum and urine samples 
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from three snakebite victims seen at the Springdale Medical Clinic in 
Oklahoma City, Oklahoma during 1984-1986. In general, urine samples were 
far more likely to give positive results than were serum samples. In 
some cases, serum samples failed to give positive results whereas urine 
samples taken on the same day from the same individual tested positive. 
Since this was a clinical situation, serum and urine samples from each 
patient were not taken at identical times following the bite. Therefore, 
it is only possible to make generalized statements about the appearance 
and disappearance of the venom from the serum and urine. Usually the 
venom first appeared in the urine on the same day of the bite and was 
still present the following day. On subsequent days, urine samples from 
some patients gave positive results whereas others did not. In one 
patient, the urine gave a positive reaction six days after the bite. 
These differences between patients could be explained by physiological 
differences in the clearance by the kidney and/or by variations in the 
amount of venom injected by the snakes. 
A consistent result using the ELISA in this investigation was the 
high absorbance values in human serum and urine negative controls 
compared to incubation buffer blanks. The higher absorbance values in 
the serum and urine controls made interpretation of results difficult and 
could be caused by several factors. Crude copperhead antisera were used 
in this investigation and it is possible that natural antibodies in the 
antiserum were cross-reacting with components in the human serum and 
urine. Also, endogenous alkaline phosphatase present in the serum and 
urine could be binding to the microtiter plates and reacting with the 
substrate added to the wells. Since results of screening negative 
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control serum and urine from several people show that the absorbance 
values differ considerably between individuals, incubation buffer or 
normal pooled serum and urine purchased from commercial sources are not 
good negative controls for the assay. The results of this investigation 
suggest that in a clinical situation where control serum and urine 
obtained before the snakebite are usually not available, serum and urine 
should be taken from an individual over a period of time and the sample 
giving the lowest absorbance value used as a negative control. However, 
in treating snakebite in the clinic, the diagnosis of the bite and the 
identity of the offending snake must be determined within a few hours if 
antivenom is to be effectively administered. Because the length of time 
required to obtain several samples from a patient in order to get a 
negative control would limit the effectiveness of the assay in the 
diagnosis of snakebite, many clinicians may be inclined to use pooled 
serum and urine as negative controls. Caution must be made, however, in 
interpreting positive ELISA results using these controls because of the 
individual variation in human serum and urine samples. 
The A. c. contortrix venom standards made in normal human serum at 
concentrations ranging from 250 to 61.5 ng/ml constistently gave 
absorbance values 60-70% lower than standards made in incubation buffer. 
The standards made in normal human urine were not inhibited and gave 
absorbance values that were similar to standards made in incubation 
buffer. The addition of 0.5 mg/ml human alpha-2 macroglobulin to 
standards made in incubation buffer also resulted in about 30% reduction 
in the aborbance values; this is approximately half the reduction seen 
with normal serum, however, alpha-2 macroglobulin is normally present in 
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the serum at concentrations of 2-3 mg/ml. Human alpha-2 macroglobulin is 
a non-specific protease inhibitor with a molecular weight of 750,000 and 
has been shown to form complexes with certain snake venom proteases 
(Kress and Catanese, 1981). Copperhead venoms possess considerable 
proteolytic activity on substrates such as TAr1E and BAEE (Tu et al., 
1965) and may contain more than one protease. If the proteases in 
copperhead venoms are also immunogenic, then a large number of antibodies 
in a copperhead antiserum will be specific for these components. It is 
possible that alpha-2 macroglobulin can form complexes with these 
copperhead venom proteases and thus inhibit antibodies from binding. The 
inhibition could result from either an alteration of the epitope on the 
protease or by steric hindrence of the alpha-2 macroglobulin. Since the 
binding of alpha-2 macroglobulin to proteases is irreversible (Swenson 
and Howard, 1979), the presence of the molecule in serum would 
effectively inhibit the ELISA assay. This could explain the reduced 
capability of the assay to detect the venom in the serum in this and 
other investigations (Hurrell and Chandler, 1982) and suggests that 
samples, such as bite site washings, that do not come in contact with 
this particular serum component would be more likely to give positive 
ELISA results following a snakebite. 
The standards made with human serum albumin were not significantly 
different from those made in incubtion buffer. Therefore, human serum 
albumin does not appear to interfere with the ELISA in detecting 
copperhead venom. Human serum albumin, unlike certain other mammalian 
albumins, apparently does not interact with snake venom components, at 
least to the extent of inhibiting their reactivity in the ELISA. 
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The results of the addition of human IgG to~~ contortrix venom 
standards are interesting in that they consistently gave higher 
absorbance values at low venom concentrations compared to standards made 
in incubation buffer or those containing human serum albumin. This was 
seen using both the double-antibody and indirect ELISA methods. One 
possible explanation for this is that human IgG molecules were cross-
reacting with the goat anti-rabbit IgG antibodies of the conjugate. This 
could also explain the high blank values in negative control serum and 
urine compared to incubation buffer blanks. 
The cross-reaction studies indicated that a large number of 
crotaline snake venoms cross-react with copperhead antisera. The cross-
reaction varied between snake species and did not appear to follow any 
phylogenetic pattern. Therefore, based on the results of this 
investigation it does not appear possible to accurately determine the 
identity of a snake as a copperhead or other crotaline snake using an 
enzyme-linked immunosorbent assay in the clinic. However, a crude 
antiserum against copperhead venom was used, and it is possible an 
antiserum produced against an individual component of copperhead venom 
which is not present in other crotaline venoms may be used to overcome 
this problem of cross-reaction. 
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